Oxea reports increased revenues and earnings in Q4
Net sales
Net sales for the three months ended December, 2012 were €342.9 million, an increase of 4.4% compared with the corresponding period of the prior year. Overall, volumes were 2.6% higher compared with Q4 2011. Oxo Intermediates volumes were up by 1.7% and Oxo Derivatives volumes traded 5.9% higher. Of our revenues for the three months ended December 31, 2012, €158 million resulted from sales in Europe, €115 million in North America, and €69 million in the rest of the world compared to €141 million, €109 million, and €78 million, respectively, in the prior year period.
Gross profit
Gross profit for the three months ended December 31, 2012 amounted to €47.1 million compared with €33.8 million in Q4 2011, mainly due to higher sales and improved margins.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.